Our CEO Mike Uchrin recently joined The Pulse Podcast by Wharton Digital Health to share how Monogram Health is transforming the care landscape for chronic kidney disease (CKD) and end-stage kidney disease (ESKD), and related polychronic conditions. From his childhood dreams and the “aha” moment that inspired the founding of Monogram to the latest innovations in kidney care and practical advice for managing kidney health, hear directly from Mike on how we’re improving patient outcomes. #CKD #ESKD #KidneyHealth #ValueBasedCare #InHomeCare #PolychronicCare
Excited to announce the latest episode of the The Pulse Podcast by Wharton Digital Health! I had the pleasure of interviewing Mike Uchrin, Co-founder and CEO of Monogram Health. Founded in 2019, Monogram Health is revolutionizing kidney care through its value-based, in-home care model, improving outcomes for patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD), as well as related polychronic conditions. By integrating evidence-based clinical protocols and personalized care delivery, Monogram ensures that CKD patients receive comprehensive support directly in their homes. The company was recently recognized as the third fastest-growing privately held company in the U.S., backed by over $350 million in funding from major healthcare players like CVS Health, The Cigna Group Ventures and Humana, among others. In the episode, Mike and I discussed: 1) Monogram’s value-based, in-home care model for CKD and ESKD patients 2) The importance of multispecialty care and evidence-based protocols in improving patient outcomes 3) Challenges of scaling nationwide while maintaining care quality 4) Innovations in kidney care, including genetic and pharmacological breakthroughs A big thanks to Mike, and I hope you enjoy the episode! Listen/Read: Medium: https://lnkd.in/ezYmHq94 Spotify: https://lnkd.in/e7hnWi4G Apple: https://lnkd.in/eGeG_8Nc SoundCloud: https://lnkd.in/eBB9f_HH] #kidneycare #valuebasedcare #homehealth #digitalhealth